|
Responsable de cette page:
|
Prof. Dr. M. Eichner
|
|
Webmaster:
|
Prof. Dr. M. Eichner
(dernière modification de cette page:
13 juli 2009)
|
|
Collaborateur:
|
Dr. M. Schwehm, ExploSYS GmbH
|
|
Autres partenaires pour ce projet:
|
J. H. Richardus, Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, The Netherlands
|
|
|
S. de Vlas, Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, The Netherlands
|
|
|
J. Burg, Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, The Netherlands
|
|
|
W. J. Meerding, Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, The Netherlands
|
|
|
W. J. Edmunds, Modelling and Economics Unit, CDSC, Health Protection Agency (HPA), United Kingdom
|
|
|
N. Gay, Modelling and Economics Unit, CDSC, Health Protection Agency (HPA), United Kingdom
|
|
|
M. Slater, Health Protection Agency (HPA), United Kingdom
|
|
|
R. Pebody, Immunisation Division, CDSC, Health Protection Agency (HPA), United Kingdom
|
|
|
A. Nardone, Immunisation Division, CDSC, Health Protection Agency (HPA), United Kingdom
|
|
|
S. Leach, Microbial Risk assessment, Health Protection Agency (HPA), United Kingdom
|
|
|
R. Gani, Microbial Risk assessment, Health Protection Agency (HPA), United Kingdom
|
|
|
G. Elam, Behavioural Surveillance Unit, CDSC, Health Protection Agency (HPA), United Kingdom
|
|
|
J. Y. Chow, CDSC, Health Protection Agency (HPA), United Kingdom
|
|
|
J.-C. Desenclos, Infectious Disease Department, Institut de Veille Sanitaire, Paris, France
|
|
|
Y. Le Strat, Institut de Veille Sanitaire, Paris, France
|
|
|
D Bitar, Institut de Veille Sanitaire, Paris, France
|
|
|
Beijing Institute of Microbiology and Epidemiology, Beijing, China
|
|
|
T. Abraham, Journalism and Media Studies Centre, Hong Kong University (HKU), Hong Kong, China
|
|
|
P. Beutels, Centrum voor de Evaluatie van Vaccinaties, Universitaire Instelling Antwerpen (UIA), Antwerpen, Belgium
|
|
|
P. van Damme, Centre for the Evaluation of Vaccination, Centrum voor de Evaluatie van Vaccinaties, Universitaire Instelling Antwerpen (UIA), Antwerpen, Belgium
|
|
|
E. van Doorslaer, Centrum voor de Evaluatie van Vaccinaties, Universitaire Instelling Antwerpen (UIA), Antwerpen, Belgium
|
|
|
N. Thiry, Centrum voor de Evaluatie van Vaccinaties, Universitaire Instelling Antwerpen (UIA), Antwerpen, Belgium
|
|
|
R. Reintjes, Hamburg University of Applied Sciences (HAW), Department of Public Health, Hamburg, Germany
|
|
|
A. Kassen, Hamburg University of Applied Sciences, Department of Public Health, Hamburg, Germany
|
|
|
M. Aerts, Centre for Statistics, Limburgs Universitair Centrum (LUC), Antwerp, Belgium
|
|
|
H. Geys, Centre for Statistics, Limburgs Universitair Centrum (LUC), Antwerp, Belgium
|
|
|
Z. Shkedy, Centre for Statistics, Limburgs Universitair Centrum (LUC), Antwerp, Belgium
|
|
|
C. Faes, Centre for Statistics, Limburgs Universitair Centrum (LUC), Antwerp, Belgium
|
|
|
P. Ruutu, National Public Health Institute (KTL), Department of Infectious Disease Epidemiology, Helsinki, Finland
|
|
|
K. Auranen, National Public Health Institute (KTL), Department of Infectious Disease Epidemiology, Helsinki, Finland
|
|
|
A. R. Aro, National Public Health Institute (KTL), Department of Epidemiology and Health Promotion, Helsinki, Finland
|
|
|
P. Leinikki, National Public Health Institute (KTL), Department of Infectious Disease Epidemiology, Helsinki, Finland
|
|
|
A. Uutela, National Public Health Institute (KTL), Department of Epidemiology and Health Promotion, Helsinki, Finland
|
|
|
A.-M. Vartti, National Public Health Institute (KTL), Department of Infectious Disease Epidemiology, Helsinki, Finland
|
|
|
M. Keeling, Ecology and Epidemiology, University of Warwick, Coventry, United Kingdom
|
|
|
J. Wallinga, Centre for Infectious Disease Epidemiology, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands
|
|
|
P. Teunis, Computerization and Methodological Consultancy Unit, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands
|
|
|
M. Kretzschmar, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands
|
|
|
F. Woudenberg, Department of Infectious Diseases, Municipal Health Service Rotterdam (MHSR), Rotterdam, The Netherlands
|
|
|
O. de Zwart, Department of Infectious Diseases, Municipal Health Service Rotterdam (MHSR), Rotterdam, The Netherlands
|
|
|
T.-H. Wang, Center for Disease Control Taiwan, Taiwan
|
|
|
R. Smith, School of Medicine, Health Policy and Practice, University of East Anglia (UEA), Norwich, United Kingdom
|
|
|
M. Yago, School of Medicine, Health Policy and Practice, University of East Anglia (UEA), Norwich, United Kingdom
|
|
|
S. Salmaso, Communicable Disease Epidemiology Unit (CDEU), Istituto Superiore di Sanità (ISS), Rome, Italy
|
|
|
A. Merianos, Department of Communicable Disease and Response, The World Health Organization (WHO), Geneva, Switzerland
|
|
|
B. Ganter, The World Health Organization Office for Europe (WHO-EURO) Communicable Disease Surveillance and Response, Geneva, Switzerland
|
|
|
G. Nylen, The World Health Organization Office for Europe (WHO-EURO) Communicable Disease Surveillance and Response, Geneva, Switzerland
|
|
|
M. van Genugten, MAPI Values (MAPI), Utrecht, The Netherlands
|
|
Soutenu financièrement par:
|
European Comission
|
|
Avertissement:
|
L'Université Eberhard Karl de Tübingen,
le Centre Hospitalier Universitaire de Tübingen,
le Département de Biométrie Médicale (IMB),
ainsi que les auteurs de cette page déclinent toute responsabilité pour le contenu des pages auxquelles cette page renvoie
|
Vous êtes le
éme visiteur de notre site.
|
|
